- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaThe updated criteria for the diagnosis of myeloma represent a [...]
- Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working GroupWhole Body Low Dose CT (WBLDCT) has important advantages as [...]
- Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American CountriesLatin American countries (LATAMC) represent a large fraction of patients [...]
- Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working GroupFor decades conventional skeletal survey (CSS) has been the standard [...]
- Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG studyIntroduction of new myeloma therapies offers new options for patients [...]
ASCT
bone disease
bortezomib
classification
computed tomography
consensus
cytogenetics
diagnosis
DVT
genetic
guidelines
IMWG
International myeloma working group
International Staging System
ISS
lenalidomide
magnetic resonance imaging
molecular
multiple myeloma
myeloma
patients
prognosis
response criteria
stem cell
survival
thalidomide
therapy
thrombosis
transplantation
treatment
Categories
- Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy Search